Pharmaceuticals

Our new Group purpose and purpose by each business can be found here

Overview

JT is committed to the research and development of world-class, innovative drugs.

Our pharmaceutical business aims to create innovative, original drugs to support patients in the shortest time possible.

As this business has a direct impact on human health and life, we not only strictly comply with all laws, regulations, and industry standards, but are also guided by a strong sense of ethics and responsibility. This is particularly the case in areas such as clinical trials and promoting drugs, as well as animal experiments and managing chemical substances.

JT concentrates on R&D, while Torii Pharmaceutical Co., Ltd. is in charge of sales and promotion in the Japanese domestic market.

Notes: Regarding manufacturing, we outsource the entire process of manufacturing operations to contracted factories. Outside of Japan, we do not have a sales function, but we do license drugs to other pharmaceutical manufacturers.

Our pharmaceutical business value chain*

* This diagram represents the value chain of products developed by JT, and sold and promoted by Torii Pharmaceutical.

Pharmaceutical business sustainability strategy

Our pharmaceutical business aims to create innovative, original drugs to support patients in the shortest time possible. We are committed to the research and development of world-class, innovative drugs.

In view of this mission, in 2019, we selected the three focus areas below and set five specific targets for these focus areas.

Focus areas	Aspirational goals
Products and services	We will create innovative, original drugs to support patients in the shortest time possible.
People	We will strive to nurture talent development which enables us to create first-in-class (FIC) drugs.
Product safety and responsibility	We will strictly comply with all relevant laws, regulations, and industry standards in order to deliver safe drugs to patients.